Trials / Completed
CompletedNCT02475460
HeartMate 3™ LIS Study
Thoratec Corporation HeartMate 3™ Less Invasive Surgery (LIS) Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate a less invasive implantation technique of the HeartMate 3 Left Ventricular Assist System (HM 3 LVAS) in 10 patients.
Detailed description
This study will evaluate the less invasive implantation technique of the HM 3 LVAS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Less Invasive Surgery (LIS) | Less invasive HM 3 LVAD surgical implant procedure |
| DEVICE | HeartMate 3™ | HM 3 LIS |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-01-01
- Completion
- 2016-07-01
- First posted
- 2015-06-18
- Last updated
- 2022-06-24
Locations
3 sites across 2 countries: Czechia, Germany
Source: ClinicalTrials.gov record NCT02475460. Inclusion in this directory is not an endorsement.